logo
  • Home
  • About Us
  • Cognition
  • Pipeline
  • News
  • Talent
  • Contact
中
  • In January 2024, the Drug Evaluation Center (CDE) of the State Food and Drug Administration accepted a total of 1 and 7 new stem cell-related drugs with clinical implied approval
    2024-02-22
  • Is it safe to infuse mesenchymal stem cells? Multiple international authoritative journals answer!
    2024-02-21
  • Face the challenge of iPSC patent medicine, and the fatal risk associated with efficacy -iPSC tumor-causing gradually break!
    2024-02-20
  • Step into the Stem Cell era: Take stock of the breakthrough progress made in stem cell therapy in 2023!
    2024-02-19
  • A study by Kunming Medical Science University Ganmei Hospital shows that stem cells can improve the survival rate and quality of life of liver transplant patients
    2024-02-06
Prev
... 44 45 46 47 48 ...
Next
logo

Phone:021-64051958

Email:info@yuanvore.com

  • Cognition
    Cognition
    CellBank
    Platform
    Patent
  • Pipeline
    PipelineLayout
  • News
    Industry Trends
    Technological Frontier
    Information of YuanVore
  • Talent
    Enterprise Culture
    Job Information
  • About Us
    Contact Us
CopyRight @ 2023 Shanghai Yuanvore Medicine Technology Co., Ltd. AIl Rights Reserved 沪ICP备2023021701号

沪公网安备31011202020042号